143 related articles for article (PubMed ID: 37333273)
1. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway.
Wang S; Böhnert V; Joseph AJ; Sudaryo V; Swinderman J; Yu FB; Lyu X; Skariah G; Subramanyam V; Gilbert LA; Goodarzi H; Lingyin L
bioRxiv; 2023 Jun; ():. PubMed ID: 37333273
[TBL] [Abstract][Full Text] [Related]
2. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.
Wang S; Böhnert V; Joseph AJ; Sudaryo V; Skariah G; Swinderman JT; Yu FB; Subramanyam V; Wolf DM; Lyu X; Gilbert LA; Van't Veer LJ; Goodarzi H; Li L
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2313693120. PubMed ID: 38117852
[TBL] [Abstract][Full Text] [Related]
3. Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint.
Mardjuki R; Wang S; Carozza J; Zirak B; Subramanyam V; Abhiraman G; Lyu X; Goodarzi H; Li L
Cell Rep; 2024 May; 43(5):114209. PubMed ID: 38749434
[TBL] [Abstract][Full Text] [Related]
4. ENPP1's regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling.
Carozza JA; Cordova AF; Brown JA; AlSaif Y; Böhnert V; Cao X; Mardjuki RE; Skariah G; Fernandez D; Li L
Proc Natl Acad Sci U S A; 2022 May; 119(21):e2119189119. PubMed ID: 35588451
[TBL] [Abstract][Full Text] [Related]
5. Identification of extracellular membrane protein ENPP3 as a major cGAMP hydrolase, cementing cGAMP's role as an immunotransmitter.
Mardjuki R; Wang S; Carozza JA; Abhiraman GC; Lyu X; Li L
bioRxiv; 2024 Jan; ():. PubMed ID: 38260585
[TBL] [Abstract][Full Text] [Related]
6. Extracellular cGAMP is a cancer cell-produced immunotransmitter involved in radiation-induced anti-cancer immunity.
Carozza JA; Böhnert V; Nguyen KC; Skariah G; Shaw KE; Brown JA; Rafat M; von Eyben R; Graves EE; Glenn JS; Smith M; Li L
Nat Cancer; 2020 Feb; 1(2):184-196. PubMed ID: 33768207
[TBL] [Abstract][Full Text] [Related]
7. Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling.
An Y; Zhu J; Xie Q; Feng J; Gong Y; Fan Q; Cao J; Huang Z; Shi W; Lin Q; Wu L; Yang C; Ji T
Adv Sci (Weinh); 2024 May; 11(20):e2308131. PubMed ID: 38498770
[TBL] [Abstract][Full Text] [Related]
8. Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone.
Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
Biochem Pharmacol; 2024 Feb; 220():116006. PubMed ID: 38142838
[TBL] [Abstract][Full Text] [Related]
9. Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.
Li J; Duran MA; Dhanota N; Chatila WK; Bettigole SE; Kwon J; Sriram RK; Humphries MP; Salto-Tellez M; James JA; Hanna MG; Melms JC; Vallabhaneni S; Litchfield K; Usaite I; Biswas D; Bareja R; Li HW; Martin ML; Dorsaint P; Cavallo JA; Li P; Pauli C; Gottesdiener L; DiPardo BJ; Hollmann TJ; Merghoub T; Wen HY; Reis-Filho JS; Riaz N; Su SM; Kalbasi A; Vasan N; Powell SN; Wolchok JD; Elemento O; Swanton C; Shoushtari AN; Parkes EE; Izar B; Bakhoum SF
Cancer Discov; 2021 May; 11(5):1212-1227. PubMed ID: 33372007
[TBL] [Abstract][Full Text] [Related]
10. Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP.
Carozza JA; Brown JA; Böhnert V; Fernandez D; AlSaif Y; Mardjuki RE; Smith M; Li L
Cell Chem Biol; 2020 Nov; 27(11):1347-1358.e5. PubMed ID: 32726585
[TBL] [Abstract][Full Text] [Related]
11. Stimulating STING for cancer therapy: Taking the extracellular route.
Li L
Cell Chem Biol; 2024 May; 31(5):851-861. PubMed ID: 38723635
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Orally Bioavailable Phthalazinone Analogues as an ENPP1 Inhibitor for STING-Mediated Cancer Immunotherapy.
Cho Y; Kang M; Ji SH; Jeong HJ; Jung JE; Oh DH; Park S; Park YY; Choi J; Kim S; Kim NJ; Lee DH; Park CS; Han SJ; Lee S; Choi J
J Med Chem; 2023 Nov; 66(22):15141-15170. PubMed ID: 37963811
[TBL] [Abstract][Full Text] [Related]
13. AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model.
Goswami A; Deb B; Goyal S; Gosavi A; Mali M; Martis AM; Khurana P; Gangar M; Raykar D; Mohanty A; Kulkarni A
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235254
[TBL] [Abstract][Full Text] [Related]
14. Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy.
Wang X; Lu X; Yan D; Zhou Y; Tan X
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806118
[TBL] [Abstract][Full Text] [Related]
15. Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS-cGAMP-STING Pathway.
Ritchie C; Carozza JA; Li L
Annu Rev Biochem; 2022 Jun; 91():599-628. PubMed ID: 35287475
[TBL] [Abstract][Full Text] [Related]
16. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
Mekers VE; Kho VM; Ansems M; Adema GJ
Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
[TBL] [Abstract][Full Text] [Related]
17. Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects.
Guan D; Fang L; Feng M; Guo S; Xie L; Chen C; Sun X; Wu Q; Yuan X; Xie Z; Zhou J; Zhang H
Eur J Med Chem; 2024 Mar; 267():116211. PubMed ID: 38359537
[TBL] [Abstract][Full Text] [Related]
18. ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity.
Wang L; Cao L; Li Z; Shao Z; Chen X; Huang Z; He X; Zheng J; Liu L; Jia XM; Xiao H
J Immunol; 2024 Jun; ():. PubMed ID: 38847616
[TBL] [Abstract][Full Text] [Related]
19. T Cell-Derived Apoptotic Extracellular Vesicles Hydrolyze cGAMP to Alleviate Radiation Enteritis via Surface Enzyme ENPP1.
Zhou Y; Bao L; Gong S; Dou G; Li Z; Wang Z; Yu L; Ding F; Liu H; Li X; Liu S; Yang X; Liu S
Adv Sci (Weinh); 2024 Jun; ():e2401634. PubMed ID: 38888507
[TBL] [Abstract][Full Text] [Related]
20. SLC19A1 Is an Importer of the Immunotransmitter cGAMP.
Ritchie C; Cordova AF; Hess GT; Bassik MC; Li L
Mol Cell; 2019 Jul; 75(2):372-381.e5. PubMed ID: 31126740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
